19-38504715-ACCT-A
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000540.3(RYR1):c.8068-29_8068-27delCCT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.282 in 1,611,506 control chromosomes in the GnomAD database, including 68,568 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.33 ( 9153 hom., cov: 0)
Exomes 𝑓: 0.28 ( 59415 hom. )
Consequence
RYR1
NM_000540.3 intron
NM_000540.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.613
Publications
3 publications found
Genes affected
RYR1 (HGNC:10483): (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
RYR1 Gene-Disease associations (from GenCC):
- malignant hyperthermia, susceptibility to, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, Ambry Genetics
- congenital multicore myopathy with external ophthalmoplegiaInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
- RYR1-related myopathyInheritance: AR, AD Classification: DEFINITIVE Submitted by: ClinGen
- central core myopathyInheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
- King-Denborough syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- malignant hyperthermia of anesthesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive centronuclear myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- benign Samaritan congenital myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- congenital myopathy with myasthenic-like onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- lethal multiple pterygium syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 19-38504715-ACCT-A is Benign according to our data. Variant chr19-38504715-ACCT-A is described in ClinVar as Benign. ClinVar VariationId is 256570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.455 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.334 AC: 50542AN: 151246Hom.: 9111 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
50542
AN:
151246
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.324 AC: 81212AN: 250880 AF XY: 0.323 show subpopulations
GnomAD2 exomes
AF:
AC:
81212
AN:
250880
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.277 AC: 403925AN: 1460142Hom.: 59415 AF XY: 0.281 AC XY: 204139AN XY: 726388 show subpopulations
GnomAD4 exome
AF:
AC:
403925
AN:
1460142
Hom.:
AF XY:
AC XY:
204139
AN XY:
726388
show subpopulations
African (AFR)
AF:
AC:
15485
AN:
33424
American (AMR)
AF:
AC:
17451
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
AC:
6844
AN:
26132
East Asian (EAS)
AF:
AC:
13394
AN:
39682
South Asian (SAS)
AF:
AC:
38471
AN:
86152
European-Finnish (FIN)
AF:
AC:
15582
AN:
53324
Middle Eastern (MID)
AF:
AC:
1733
AN:
5236
European-Non Finnish (NFE)
AF:
AC:
277090
AN:
1111200
Other (OTH)
AF:
AC:
17875
AN:
60296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
15389
30777
46166
61554
76943
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
9670
19340
29010
38680
48350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.335 AC: 50643AN: 151364Hom.: 9153 Cov.: 0 AF XY: 0.341 AC XY: 25216AN XY: 73908 show subpopulations
GnomAD4 genome
AF:
AC:
50643
AN:
151364
Hom.:
Cov.:
0
AF XY:
AC XY:
25216
AN XY:
73908
show subpopulations
African (AFR)
AF:
AC:
18964
AN:
41194
American (AMR)
AF:
AC:
5439
AN:
15198
Ashkenazi Jewish (ASJ)
AF:
AC:
933
AN:
3468
East Asian (EAS)
AF:
AC:
1835
AN:
5106
South Asian (SAS)
AF:
AC:
2209
AN:
4796
European-Finnish (FIN)
AF:
AC:
3025
AN:
10466
Middle Eastern (MID)
AF:
AC:
92
AN:
294
European-Non Finnish (NFE)
AF:
AC:
17187
AN:
67840
Other (OTH)
AF:
AC:
722
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1622
3244
4866
6488
8110
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
496
992
1488
1984
2480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1701
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Oct 25, 2013
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Congenital multicore myopathy with external ophthalmoplegia Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
May 25, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
King Denborough syndrome Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Central core myopathy Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.